Tfc Financial Management Laboratory Corp Of America Holdings Transaction History

Tfc Financial Management

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	BUY	$209.01 - $232.56 $209 - $232	1 Added 1.01%	100 $21,000
Q4 2023 Jan 25, 2024	BUY	$197.69 - $227.29 $395 - $454	2 Added 2.06%	99 $22,000
Q2 2023 Aug 07, 2023	SELL	$211.93 - $241.33 $7,417 - $8,446	-35 Reduced 26.52%	97 $23,000
Q1 2023 May 08, 2023	BUY	$213.32 - $257.83 $7,466 - $9,024	35 Added 36.08%	132 $30,000
Q4 2022 Feb 13, 2023	BUY	$203.72 - $248.97 $19,760 - $24,150	97 New	97 $22,000
Q2 2021 Jul 29, 2021	SELL	$251.87 - $278.14 $14,608 - $16,132	-58 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$167.03 - $201.3 $9,687 - $11,675	58 New	58 $11,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $21.7B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Tfc Financial Management, based on Form 13F filings with the SEC.

Stay updated on Tfc Financial Management with notifications on news.